InsiderTrades

Form 4 for TARA Protara Therapeutics, Inc.

Accepted 2024-01-23 00:00:00 ET · period of report 2024-01-19 · accession 0001213900-24-005722 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-23 2024-01-19 TARA Fry Hannah VP, Ctrl A - Grant $0.00 +8,000 30.7K +35% $0
D 2024-01-23 2024-01-19 TARA Fry Hannah VP, Ctrl F - Tax $1.91 -904 29.8K -3% -$1,727
D 2024-01-23 2024-01-19 TARA Fry Hannah VP, Ctrl A - Grant $0.00 +46.0K 46.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-19 A A 8,000 $0.00 30,740 D — — (F1) The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
2 Common Common Stock 2024-01-19 F D 904 $1.91 29,836 D — — (F3) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023.
3 Derivative Stock Option (Right to Buy) 2024-01-19 A A 46,000 $0.00 46,000 D $1.91 · — to 2034-01-18 46,000 Common Stock (F2) 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.